Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions.

ABSTRACT:

Background

Colorectal cancer (CRC) requires the presence of a variety of factors predisposing a tumorigenic milieu. Excluding familial clustering and hereditary CRC syndromes, the development of sporadic CRC from precancerous lesions is influenced by tissue inflammation, modulation of intestinal immunity, hormones, dietary habits and gut microbiota composition. As concerning the last two aspects, the intestinal presence of equol, the most biologically active metabolite of the soy isoflavone daidzein and the presence of a genetic determinant of gut microbiota able to metabolize daidzein, seem to lower the CRC risk. It has been hypothesized that the anaerobic microorganisms of the Bacteroides genus play a role in equol production.

Aim

To evaluate the presence of (i) ana

SUBMITTER: Polimeno L 

PROVIDER: S-EPMC7232402 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature